When inflammation shifts to malignancy: extensive squamous cell carcinoma in a female hidradenitis suppurativa/acne inversa patient;Wenn Entzündung in Malignität übergeht: ausgedehntes Plattenepithelkarzinom bei einer Patientin mit Hidradenitis suppurativa/Acne inversa

JDDG - Journal of the German Society of Dermatology

Volumn 15, Issue 1, 2017, Pages 86-88

  Hessam, Schapoor ^a   Sand, Michael ^a   Bechara, Falk G ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ACNE INVERSA; ADULT; CANCER SURGERY; CASE REPORT; DISEASE CLASSIFICATION; FEMALE; HUMAN; HURLEY CLASSIFICATION; INCISION; INFLAMMATION; LETTER; LYMPH NODE METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; SQUAMOUS CELL SKIN CARCINOMA; SUPPURATIVE HIDRADENITIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS;

EID: 85007436615     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12911     Document Type: Letter

References (11)

1. Kirschke J, Hessam S, Bechara FG. [Hidradenitis suppurativa/ acne inversa: An update]. Hautarzt 2015; 66: 413-22.
2. Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 2007; 89: 709-12.
3. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-61; quiz 562-3.
4. Pena ZG, Sivamani RK, Konia TH, Eisen DB. Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature. Dermatol Online J 2015; 21(4). pii: 13030/qt9q9707dp.
5. Bechara FG, Sand M, Skrygan M et al. Acne inversa: evaluating antimicrobial peptides and proteins. Ann Dermatol 2012; 24: 393-7.
6. Hessam S, Sand M, Gambichler T, Bechara FG. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol 2015; 73(6): 998-1005.
7. Kundu JK, Surh Y-J. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659: 15-30.
8. Kimball AB, Kerdel F, Adams D et al. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med 2012; 157: 846-55.
9. Turculeanu A, Mogoantă CA, IoniŢă E et al. TNF-α evaluation in tonsil cancer. Rom J Morphol Embryol 2015; 56(1): 101-6.
10. Zitelli KB, Zedek D, Ranganathan P, Amerson EH. Squamous cell carcinoma of the lip associated with adalimumab therapy for ankylosing spondylitis: a case report and review of TNF-α inhibitors and cutaneous carcinoma risk. Cutis 2013; 92: 35-9.
11. Popivanova BK, Kitamura K, Wu Y et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008; 118: 560-70.